470-03-1 (表菝契皂苷元,Spirostan-3-ol; (3α,5β,25S)-form)

表菝契皂苷元;

5\',6a,8a,9-tetramethyldocosahydrospiro[naphtho[2\',1\':4,5]indeno[2,1-b]furan-10,2\'-pyran]-4-ol;470-03-1;GMBQZIIUCVWOCD-RHHRBMONSA-N;NSC 231816;epi-Sarsasapogenin;(25s)3alpha-hydroxy-5beta-spirostane;(3alpha,5beta,25S)-Spirostan-3-ol;Spirostan-3-ol, (3alpha,5beta,25S)-;Episarsasapogenin;SCHEMBL15335261;(1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S,16R,18R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-16-ol;3-Episarsasapogenin;

GMBQZIIUCVWOCD-UHFFFAOYSA-N

1S/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3

CC1C2(OCC(C)CC2)OC2CC3C(C12)(C)CCC1C3CCC2C1(C)CCC(O)C2